PTC Therapeutics, Inc.PTCTNASDAQ
LOADING
|||
Switch Symbol:
Net Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year net income growth rate
Latest
124.51%
↑ 833% above average
Average (39q)
-16.99%
Historical baseline
Range
High:1415.24%
Low:-1616.77%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 124.51% |
| Q2 2025 | -107.48% |
| Q1 2025 | 1415.24% |
| Q4 2024 | 38.22% |
| Q3 2024 | -7.54% |
| Q2 2024 | -8.30% |
| Q1 2024 | 41.22% |
| Q4 2023 | -17.16% |
| Q3 2023 | 33.14% |
| Q2 2023 | -43.12% |
| Q1 2023 | 18.68% |
| Q4 2022 | -56.33% |
| Q3 2022 | 28.12% |
| Q2 2022 | -20.01% |
| Q1 2022 | 11.54% |
| Q4 2021 | -7.22% |
| Q3 2021 | -12.89% |
| Q2 2021 | 7.98% |
| Q1 2021 | -73.01% |
| Q4 2020 | -6.69% |
| Q3 2020 | 61.59% |
| Q2 2020 | -61.00% |
| Q1 2020 | -45.07% |
| Q4 2019 | -29.47% |
| Q3 2019 | -43.57% |
| Q2 2019 | 42.05% |
| Q1 2019 | -49.21% |
| Q4 2018 | 5.18% |
| Q3 2018 | -435.39% |
| Q2 2018 | 50.58% |
| Q1 2018 | -1616.77% |
| Q4 2017 | 103.76% |
| Q3 2017 | -93.06% |
| Q2 2017 | 39.86% |
| Q1 2017 | -8.44% |
| Q4 2016 | 23.80% |
| Q3 2016 | 9.63% |
| Q2 2016 | 5.62% |
| Q1 2016 | 19.07% |
| Q4 2015 | -17.87% |